There are 594 resources available
92P - Real-world treatment sequencing and outcomes in ALK-positive metastatic non-small cell lung cancer
Presenter: Martin Dietrich
Session: Poster Display session
93P - Next generation ALK inhibitors and metastatic NSCLC with ALK gene rearrangements, a 2 × 2 head to head comparison using RWD from TriNetX database
Presenter: Carlos Henrique Andrade Teixeira
Session: Poster Display session
94P - Long-term efficacy of lorlatinib vs alectinib in patients with and without brain/central nervous system metastases: Matching-adjusted indirect comparisons
Presenter: Julien Mazieres
Session: Poster Display session
95P - Adagrasib (ADA) plus cetuximab (CETUX) in patients (pts) with advanced KRASG12C-mutated non-small cell lung cancer (NSCLC) from KRYSTAL-1
Presenter: Jun Zhang
Session: Poster Display session
96P - Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)
Presenter: Loic Verlingue
Session: Poster Display session
97P - Matching-adjusted indirect comparison (MAIC) of sotorasib vs adagrasib for previously treated advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation
Presenter: Jürgen Wolf
Session: Poster Display session
98P - Exploratory analysis showed increased overall survival among non-small cell lung cancer (NSCLC) patients with mutated KRAS compared with wildtype KRAS in a phase II trial of mecbotamab vedotin (CAB-AXL-ADC)
Presenter: Karen Reckamp
Session: Poster Display session
99P - The effect of KRAS mutation subtypes on the efficacy of first-line pembrolizumab in stage IV non-small cell lung cancer patients with high PD-L1 expression
Presenter: Patrizia Froesch
Session: Poster Display session
100P - Clinical spectrum and outcomes of KRAS mutated advanced stage NSCLC
Presenter: An-Sofie D'hulster
Session: Poster Display session
101P - European results from the 2024 International Association for the Study of Lung Cancer (IASLC) global survey on biomarker testing
Presenter: Matthew Smeltzer
Session: Poster Display session